Description
Flexible, integrated solutions for highly potent oral targeted therapies
At PCI, we combine deep expertise in highly potent API (HPAPI) development with access to advanced solubility technologies – offering fully integrated, flexible solutions for your targeted oral therapies.
We support the development and manufacturing of oral targeted therapies through a flexible model. With deep expertise in the processing of highly potent molecules built over 35 years and through a trusted partner network, we act as your single point of contact across the full CDMO journey.
We take an pure approach to development; we build the process around your product and not our setup. Throughout our 35 years of developing and manufacturing highly potent products, we have supported a wide range of oral drug products classified as being highly potent, and through this experience and expertise, we are able to support almost any project.
We understand that solubility can present major challenges with some modalities, and we are able to bring proven strategic development options. Our network includes renowned specialists in spray drying, hot melt extrusion (HME), and solubility enhancement solutions, which are fully integrated with our development strategies. Our in-house subject matter experts are here to support you at every step of the process and identify the potential development pathways for your drug product. At PCI, we act as the conduit for all development work, acting as your single point of contact throughout the development process.